1.
Federico M, Luminari S, Pellegrini C, Merli F, Pesce EA, Chauvie S, Gandolfi L, Capodanno I, Salati M, Argnani L, Zinzani PL. Brentuximab vedotin followed by ABVD +/− radiotherapy in patients with previously untreated Hodgkin lymphoma: final results of a pilot phase II study. Haematologica [Internet]. 2016Mar.31 [cited 2026Nov.1];101(4):e139-e141. Available from: https://haematologica.org/article/view/7692